Table 1.
Baseline demographics summary and clinical parameters
Demographic/statistic or category |
Control (n = 53) |
Regimen (n = 54) |
Overall (N = 107) |
pvalue |
Age (years) | ||||
Mean (SD) |
47.6 (10.29) |
45.9 (10.79) |
46.7 (10.53) |
0.4075a |
Min–Max |
28–64 |
29–63 |
28–64 |
|
Sex | ||||
Femaleb, n (%) |
26 (49) |
27 (50) |
53 (50) |
1.0000c |
Maleb, n (%) |
27 (51) |
27 (50) |
54 (50) |
|
Tobacco | ||||
Nob, n (%) |
46 (87) |
46 (85) |
92 (86) |
1.0000c |
Yesb, n (%) |
7 (13) |
8 (15) |
15 (14) |
|
Mean GBI-BS |
56.11 (14.921) |
55.36 (13.723) |
55.73 (14.266) |
0.784 |
Mean MGI score (SD) |
1.69 (0.154) |
1.68 (0.129) |
1.68 (0.141) |
0.723 |
Mean PPD mm (SD) |
2.25 (0.186) |
2.25 (0.206) |
2.25 (0.195) |
0.980 |
Mean CAL mm (SD) |
2.62 (0.228) |
2.60 (0.241) |
2.61 (0.234) |
0.783 |
Mean GR mm (SD) |
0.36 (0.174) |
0.35 (0.139) |
0.36 (0.157) |
0.741 |
a2-sided ANOVApvalue for the treatment comparison
bThe number (percent) of participants in each category
c2-sided Fisher’s exact testpvalue for the treatment comparison